As the new year sparks a wave of weight loss resolutions and millions turn to weight loss medications, rising costs and the ...
Rule could make more medications available over the counter through a process called Additional Condition of Non-prescription Use (ACNU).
Stay updated on the latest potential FDA drug approvals in 2025, including an expanded label for Ozempic and new, nonopioid painkillers.
Key Takeaways Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for ...
On January 6, the FDA announced the availability of draft guidance on accelerated approval for drugs and biological products, and consideration ...
The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.
The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.
The US FDA approved the first generic referencing Victoza, a GLP-1 receptor agonist indicated to improve glycemic control.
Despite weathering significant criticism from lawmakers and patient groups over the steep cost of its rare disease med ...
ViGeneron GmbH, a clinical-stage gene therapy company based in Munich, Germany, shared details of two new milestones in an ...
Johnson & Johnson has won Food and Drug Administration priority review for its application seeking approval of nipocalimab in certain patients with generalized myasthenia gravis.
Affordable Plasma Interventions Can Have Significant Health and Economic Benefits to Prevent or Manage Age-Related Conditions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback